Overcoming Manufacturing Challenges in the Race to Market

Overcoming Manufacturing Challenges in the Race to Market

Fast on its way to becoming a multibillion-dollar market, the global cell and gene therapy industry is booming. However, challenges mean that almost three decades after the first gene therapy trial, only three gene therapies have been approved in the EU and one in the United States. This article will look into the challenges around development and manufacturing that need to be addressed so that ambitious pharma and biotechs can continue to develop these innovative medicines. 



Please note: That all fields marked with an asterisk (*) are required.